Differences in receptor binding of LDL subfractions

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 6, 1996, Pages 794-801

  Campos, Hannia ^a,b   Arnold, Kay S ^c   Balestra, Maureen E ^c   Innerarity, Thomas L ^c   Krauss, Ronald M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

apoE; cholesterol; LDL receptor; LDL size; LDL subclasses

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCLONAL ANTIBODY;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECEPTOR BINDING; SKIN FIBROBLAST;

EID: 0029888305     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.6.794     Document Type: Article

References (41)

1. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982;23:97-104.
2. Shen MMS, Krauss RM, Lindgren FT, Forte TM. Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res. 1981;22:236-244.
3. Campos H, Blijlevens E, McNamara JR, Ordovas JM, Posner BM, Wilson PWF, Castelli WP, Sehaefer EJ. Low density lipoprotein particle size distribution: results from the Framingham Offspring Study. Arterioscler Thromb. 1992;12:1410-1419.
4. Krauss RM. Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease. Am Heart J. 1987;113:578-582.
5. Krauss RM. The tangled web of coronary risk factors. Am J Med. 1991;90(suppl 2A):36s-41s.
6. Austin MA, King M-C, Vranizan KM, Newman B, Krauss RM. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet. 1988;43:838-846.
7. Austin MA, King M-C, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker of coronary heart disease risk. Circulation. 1990;82:495-506.
8. Austin MA, Breslow JL, Hennekens CH, Buring JE, Wiliett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1921.
9. Campos H, Genest J, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Sehaefer EJ. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992; 12:187-195.
10. Krauss RM. Low-density lipoprotein subclasses and risk of coronary artery disease. Curr Opin Lipidol. 1991;2:248-252.
11. Austin MA, Brunzell JD, Fitch WL, Krauss RM. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis. 1990;10:520-530.
12. Nishina PM, Johnson JP, Naggert JK, Krauss RM. Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc Natl Acad Sci USA. 1992;89:708-712.
13. Rotter JI, Bu X, Cantor RM, Warden CH, Brown J, Gray RJ, Blanche PJ, Krauss RM, Lusis AJ. Multiple genes determine LDL particle size phenotype in coronary artery disease families. Circulation. 1994;90(pt 2):I-509. Abstract.
14. Swinkels DW, Demacker PNM, Hak-Lemmers HLM, Mol MJTM, Yap SH, van't Laar A. Some metabolic characteristics of lowdensity lipoprotein subfractions, LDL-1 and LDL-2: in vitro and in vivo studies. Biochim Biophys Acta. 1988;960:1-9.
15. Jaakkola O, Solakivi T, Ylä-Herttuala S, Nikkari T. Receptor-mediated binding and degradation of subfractions of human plasma low-density lipoprotein by cultured fibroblasts. Biochim Biophys Acta. 1989;1005:118-122.
16. Swinkels DW, Hendriks JCM, Demacker PNM, Stalenhoef AFH. Differences in metabolism of three low density lipoprotein subfractions in Hep G2 Cells. Biochim Biophys Acta. 1990;1047: 212-222.
17. Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with cellular LDL receptor. J Lipid Res. 1991;32:1741-1753.
18. Chappell DA, Fry GL, Waknitz MA, Berns JJ. Ligand size as a determinant of catabolism by the low density lipoprotein (LDL) receptor pathway. J Biol Chem. 1991;266:19296-19302.
19. The Expert Panel. Report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med. 1988; 148:36-39.
20. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 1986;128: 417-431.
21. Goldstein JL, Basu SK, Brown MS. Receptor-mediated endocytosis of low density lipoproteins in cultured cells. Methods Enzymol. 1983;98:241-260.
22. Innerarity TL, Pitas RE, Mahley RW. Lipoprotein-receptor interactions. Methods Enzymol. 1986;129;542-566.
23. Arnold KS, Innerarity RL, Pitas RE, Mahley RW. Lipoprotein-receptor interactions. In: Converse CA, Skinner ER, eds. Lipoprotein Analysis: A Practical Approach. Oxford, England: IRL Press; 1991:145-168.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Polin phenol reagent. J Biol Chem. 1951;193: 265-275.
25. Milne RW, Douste-Blazy PH, Retegui L, Marcel YL. Characterization of monoclonal antibody against human apolipoprotein E. J Clin Invest. 1981;68:111-117.
26. Dreon DM, Fernstrom HA, Miller B, Krauss RM. Low-density lipoprotein subclass patterns and response to a reduced-fat diet in men. FASEB J. 1994;8:121-126.
27. C. Proc Natl Acad Sci USA. 1979;76:2311-2315.
28. Warnick GR, Nguyen T, Albers JJ. Comparison of improved precipitation methods for quantification of high density lipoprotein cholesterol. Clin Chem. 1985;31:217-222.
29. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965;2:235-254.
30. Tijssen P. Practice and theory of enzyme immunoassays. In: Burdon RH, van Knippenberg PH, eds. Laboratory Techniques in Biochemistry and Molecular Biology, Volume 15. New York, NY: Elsevier; 1985:337-343.
31. Kahlon TS, Shore VG, Lindgren FT. Heterogeneity of molecular weight and apolipoproteins in low density lipoproteins of healthy human males. Lipids. 1992;27:1055-1057.
32. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622-630.
33. Teng B, Sniderman A, Krauss RM, Kwiterovich RO Jr, Milne RW, Marcel IL. Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses. J Biol Chem. 1985;260: 5067-5072.
34. Galeano NF, Milne R, Marcel YL, Walsh MT, Levy E, Ngu'yen TD, Gleeson A, Arad Y, Witte L, Al-Haideri M, Rumsey SC, Deckelbaum RJ. Apoprotein B structure and receptor recognition of TG-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem. 1993; 269:511-519.
35. McKeone BJ, Patsch JR, Pownall HJ. Plasma triglyceride determines low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells. J Clin Invest. 1993; 91:1926-1933.
36. Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkind BM, Schonfeld G, Jacobs D, Frantz ID. Lipoprotein-cholesterol distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation. 1980;61:302-315.
37. McNamara JR, Campos H, Ordovas JM, Wilson PWF, Schaefer EJ. Effect of gender and lipid status on low density lipoprotein subfraction distribution: results from the Framingham Offspring Study. Arteriosclerosis. 1987;7:483-490.
38. Ericsson S, Eriksson M, Vitols S, Einarsson K, Berglund L, Angelin B. Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J Clin Invest. 1991;87:591-596.
39. Mahley RW, Hui DY, Innerarity TL, Weisgraber KH. Two independent lipoprotein receptors on hepatic membranes of the dog, swine, and man: apo-B,E and apo-E receptors. J Clin Invest. 1981; 68:1197-1206.
40. Rumsey SC, Obunike JC, Arad Y, Deckelbaum RJ, Goldberg IJ. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J Clin Invest. 1992;90: 1504-1512.
41. Krauss RM, Lindgren FT, Williams PT, Kelsey SF, Brensike J, Vranizan K, et al. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolemic men. Lancet. 1987;2:62-66.